Should You Buy Tilray in April?

Alex Carchidi, The Motley Fool
·5-min read
Should You Buy Tilray in April?

In that vein, Tilray (NASDAQ: TLRY) is a Canadian cannabis business that has a plan to become profitable but is still facing a big wildcard in the near future. The biggest thing for investors to consider about purchasing Tilray this month is that its upcoming merger with Aphria (NASDAQ: APHA) is very likely about to clear one of its last remaining hurdles. A vote will be held at a meeting of Tilray shareholders scheduled for April 16.